The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded, late-stage private biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.
Each year the BIO CEO & Investor Conference provides a forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry, financing promising discoveries to results in better patient outcomes.